Publications
• De Bruin ML, Sturkenboom MC, Grimaldi LM, Simo R. European Initiatives To Study Adverse Events of Treatments for Diabetes Mellitus. Pharmacoepidemiol Drug Saf. 2012; 21 (SUPPL. 3): 338. Please see http://onlinelibrary.wiley.com/doi/10.1002/pds.3324/abstract
• Vestergaard P, Starup-Linde J. Diabetes, cancer and treatment - a mini-review. Curr Drug Saf. 2013 Dec; 8(5): 292-5. Please see http://www.ncbi.nlm.nih.gov/pubmed/24215309
• Starup-Linde J, Karlstad O, Eriksen SA, Vestergaard P, Bronsveld HK, de Vries F, Andersen M, Auvinen A, Haukka J, Hjellvik V, Bazelier MT, Boer Ad, Furu K, De Bruin ML. CARING (CAncer Risk and INsulin analoGues): The Association of Diabetes Mellitus and Cancer Risk with Focus on Possible Determinants - A Systematic Review and a Meta-Analysis. Curr Drug Saf. 2013 Dec; 8(5): 296-332. Please see http://www.ncbi.nlm.nih.gov/pubmed/24215312
• Karlstad O, Starup-Linde J, Vestergaard P, Hjellvik V, Bazelier MT, Schmidt MK, Andersen M, Auvinen A, Haukka J, Furu K, de Vries F, De Bruin ML. Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies. Curr Drug Saf. 2013 Dec; 8(5): 333-48. Please see http://www.ncbi.nlm.nih.gov/pubmed/24215311
• Peeters PJ, Bazelier MT, Vestergaard P, Leufkens HG, Schmidt MK, de Vries F, De Bruin ML. Use of metformin and survival of diabetic women with breast cancer. Curr Drug Saf. 2013 Dec; 8(5): 357-63. Please see http://www.ncbi.nlm.nih.gov/pubmed/24215316
• But A, Wang H, Männistö S, Pukkala E, Haukka J. Assessing the effect of treatment duration on the association between anti-diabetic medication and cancer risk. PLoS One. 2014 Nov 24;9(11):e113162. Please see http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0113162
• Peeters PJ, Bazelier MT, Leufkens HG, de Vries F, De Bruin ML. The risk of colorectal cancer in patients with type 2 diabetes: associations with treatment stage and obesity. Diabetes Care. 2015 Mar; 38(3): 495-502. Please see http://www.ncbi.nlm.nih.gov/pubmed/?term=25552419
• Goossens ME, Zeegers MP, Bazelier MT, De Bruin ML, Buntinx F, de Vries F. Risk of bladder cancer in patients with diabetes: a retrospective cohort study. BMJ Open. 2015 Jun 1;5(6):e007470. Please see http://bmjopen.bmj.com/content/5/6/e007470.full
• Bazelier MT, Eriksson I, de Vries F, Schmidt MK, Raitanen J, Haukka J, Starup-Linde J, De Bruin ML, Andersen M. Data management and data analysis techniques in pharmacoepidemiological studies using a pre-planned multi-database approach: a systematic literature review. Pharmacoepidemiol Drug Saf. 2015 Jul 14. doi: 10.1002/pds.3828. See: http://onlinelibrary.wiley.com/doi/10.1002/pds.3828/full
• Bronsveld HK, Ter Braak B, Karlstad Ø, Vestergaard P, Starup-Linde J, Bazelier MT, De Bruin ML, de Boer A, Siezen CL, van de Water B, van der Laan JW, Schmidt MK. Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence. Breast Cancer Res. 2015 Aug 5;17(1):100. See: http://www.breast-cancer-research.com/content/17/1/100
• Goossens ME, Buntinx F, Zeegers MP, Driessen JH, De Bruin ML, de Vries F. Influence of metformin intake on the risk of bladder cancer in type 2 diabetes patients. Br J Clin Pharmacol. 2015 Aug 10. doi: 10.1111/bcp.12740. See: http://onlinelibrary.wiley.com/doi/10.1111/bcp.12740/abstract
• Paul J. H. L. Peeters, Marloes T. Bazelier, Hubert G. M. Leufkens, Anssi Auvinen, Tjeerd P. van Staa, Frank de Vries & Marie L. De Bruin (2016). Insulin glargine use and breast cancer risk: Associations with cumulative exposure. Acta Oncologica, DOI: 10.3109/0284186X.2016.1155736. See: https://www.ncbi.nlm.nih.gov/pubmed/27150973
• Bronsveld HK, Jensen V, Vahl P, De Bruin ML, Cornelissen S, Sanders J, et al. (2017). Diabetes and Breast Cancer Subtypes. PLoS ONE 12(1): e0170084. doi:10.1371/journal.pone.0170084. See: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0170084
• Bronsveld HK, Peeters PJ, de Groot MC, de Boer A, Schmidt MK, De Bruin ML. Trends in breast cancer incidence among women with type-2 diabetes in British general practice. Prim Care Diabetes. 2017 Feb 22. pii: S1751-9918(17)30024-4. See: http://www.sciencedirect.com/science/article/pii/S1751991817300244
• But A, De Bruin ML, Bazelier MT, Hjellvik V, Andersen A, Auvinen A, Starup-Linde J, Schmidt MK, Furu K, de Vries F, Karlstad Ø, Ekström N, Haukka J. Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study. Diabetologia (2017). doi:10.1007/s00125-017-4312-5. See: https://link.springer.com/article/10.1007/s00125-017-4312-5